Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study

Clinical trial NCT06950671 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06950671
Sponsor: Rahma Esam Salama Esawi
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage III Breast Cancer Invasive

Start date: 2025-09-15
Primary completion: 2028-09-15
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.